AI presents many opportunities in the women’s health space, but it can also pose considerable risks. Anyone seeking to commercialise...

Although the UK’s new R&D tax relief regime came into force on 1 April 2024, many companies have only now completed their first...

Earlier this month, Ellen Lambrix and Luca Cericola from Bristows’ Commercial & IP Transactions team attended the Licensing Executives...

The FemTech sector — technology focused on women’s health and wellness — is experiencing rapid growth in the UK. Out of the 540 active...

We explore the complexities of navigating share option plans on both sides of the Atlantic. For companies looking to reward employees...

One of the key challenges with closing the women’s health gap and expanding the number of offerings available to women (in an industry...

Femtech, short for female technology, is an important and fast growing sector. The UK is a key market for femtech as it is ranked second...

While women’s health research has been historically overlooked and underfunded, in recent years there has been a surge of activity...

In this final episode of our three-part mini series on the EU AI Act and its implications for manufacturers of medical devices, Marc...

Pod_medicaldevicesoftwaremarket As rumours swirl of a delay to the date of application of the AI Act, here is part 2 of specialists Marc...

Team-NB, representing the majority of Notified Bodies for EU MDR and IVDR medical devices, has issued a stark warning: the implementation...

On 18 March 2025, Bristows attended the Wired Health 2025 conference, which took place at Kings Place in London. It was a day gathering...